Cargando…

Is CBOP/BEP an alternative to BEP for patients with poor prognosis metastatic germ cell tumours?

Detalles Bibliográficos
Autores principales:	Addeo, A, Fusco, V, Braybrooke, JP
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070261/ https://www.ncbi.nlm.nih.gov/pubmed/27843634 http://dx.doi.org/10.1136/esmoopen-2016-000089

Ejemplares similares

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)
por: Huddart, Robert A., et al.
Publicado: (2015)

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
por: Rimmer, Y, et al.
Publicado: (2011)

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
por: Peckham, M. J., et al.
Publicado: (1983)

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948)
por: Fosså, S D, et al.
Publicado: (2005)

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.
por: de Wit, R., et al.
Publicado: (1995)

Possible hybridization schemes for BEPS
por: Grant, A
Publicado: (1972)

Protocol for the P3BEP trial (ANZUP 1302): an international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours
por: Lawrence, Nicola J., et al.
Publicado: (2018)

Adjuvant Therapy for Stage IB Germ Cell Tumors: One versus Two Cycles of BEP
por: Huddart, Robert A., et al.
Publicado: (2018)

Impact of Bep or Carboplatin Chemotherapy on Testicular Function and Sperm Nucleus of Subjects with Testicular Germ Cell Tumor
por: Ghezzi, Marco, et al.
Publicado: (2016)

BID-F1 and BID-F2 Domains of Bartonella henselae Effector Protein BepF Trigger Together with BepC the Formation of Invasome Structures
por: Truttmann, Matthias C., et al.
Publicado: (2011)

Toughened Poly(lactic acid)/BEP Composites with Good Biodegradability and Cytocompatibility
por: Wang, Qingguo, et al.
Publicado: (2019)

Mémotech structures metalliques: CAP, BEP, Bac Pro, Bac STI, BTS
por: Hazard, Claude, et al.
Publicado: (1997)

Nitride Spinel: An Ultraincompressible High‐Pressure Form of BeP(2)N(4)
por: Vogel, Sebastian, et al.
Publicado: (2019)

Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase
por: Kimakura, Mai, et al.
Publicado: (2016)

Use Incentive Approach to Promote BAT/BEP for Centralized Incineration Facilities of Medical Waste in China()
por: Ren, Yong, et al.
Publicado: (2016)

Structural basis for selective AMPylation of Rac-subfamily GTPases by Bartonella effector protein 1 (Bep1)
por: Dietz, Nikolaus, et al.
Publicado: (2021)

Structure-Function Characterization of the Conserved Regulatory Mechanism of the Escherichia coli M48 Metalloprotease BepA
por: Bryant, Jack A., et al.
Publicado: (2020)

2D BeP(2) monolayer: investigation of electronic and optical properties by driven modulated strain
por: Kansara, Shivam, et al.
Publicado: (2020)

Brief Eclectic Psychotherapy for Moral Trauma (BEP-MT): treatment protocol description and a case study
por: de la Rie, Simone M., et al.
Publicado: (2021)

Phylogenomic Analyses of Nuclear Genes Reveal the Evolutionary Relationships within the BEP Clade and the Evidence of Positive Selection in Poaceae
por: Zhao, Lei, et al.
Publicado: (2013)

Brief Eclectic Psychotherapy for Traumatic Grief (BEP-TG): toward integrated treatment of symptoms related to traumatic loss
por: Smid, Geert E., et al.
Publicado: (2015)

BepFAMN: A Method for Linear B-Cell Epitope Predictions Based on Fuzzy-ARTMAP Artificial Neural Network
por: La Marca, Anthony F., et al.
Publicado: (2022)

A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial
por: Mead, G M, et al.
Publicado: (2005)

Edge-strand of BepA interacts with immature LptD on the β-barrel assembly machine to direct it to on- and off-pathways
por: Miyazaki, Ryoji, et al.
Publicado: (2021)

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias
por: Mshaik, Rony, et al.
Publicado: (2021)

Bartonella type IV secretion effector BepC induces stress fiber formation through activation of GEF-H1
por: Wang, Chunyan, et al.
Publicado: (2021)

Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction
por: Stingl, L, et al.
Publicado: (2010)

Mémotech Plus : Métiers de l'Electrotechnique: BEP Métiers de l'Electrotechnique, BAC Professionnel Electrotechnique, Energie, Equipements Communicants
por: Bourgeois, René, et al.
Publicado: (2006)

The BDSF quorum sensing receptor RpfR regulates Bep exopolysaccharide synthesis in Burkholderia cenocepacia via interaction with the transcriptional regulator BerB
por: Steiner, Elisabeth, et al.
Publicado: (2022)

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
por: de Wit, R., et al.
Publicado: (1998)

Irradiation facilitates the inhibitory effect of the heat shock protein 90 inhibitor NVP-BEP800 on the proliferation of malignant glioblastoma cells through attenuation of the upregulation of heat shock protein 70
por: WU, JIANYUE, et al.
Publicado: (2014)

Low Survival in Poor Prognosis Metastatic Germ Cell Cancer in Belarus
por: Rolevich, Alexander I., et al.
Publicado: (2021)

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022)

Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis
por: Schlippe, M von, et al.
Publicado: (2001)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

Surgery in metastatic non-seminomatous germ cell tumours.
por: Tobias, J. S.
Publicado: (1992)

Management of poor-prognosis testicular germ cell tumors
por: Khurana, Kiranpreet, et al.
Publicado: (2010)

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.
por: Barnett, M. J., et al.
Publicado: (1993)

The role of surgery in metastatic testicular germ cell tumours (GCT).
por: Newlands, E. S., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_bu2fk5ml7hba8orgi05pqaj418